Skip to main content

UBS Group AG

Position in SOLV — Solventum Corp

CIK 1610520 ZURICH, V8

Position in SOLV

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$41,333,200
-$17,928,175 QoQ
Shares Held
632,974
-15.4% QoQ
Ownership
0.366%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in SOLV Over Time

Shares Held

Position Value (USD)

Derivatives in SOLV

reported options exposure · as of Dec 31, 2025
CallValue
$253,568
CallShares
3,200
PutValue
$253,568
PutShares
3,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Instruments & Supplies

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,098,296,053 across 53 Medical Instruments & Supplies names. SOLV ranks #12 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SOLV

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $41,333,200 632,974
2025-12-31 $253,568 3,200
2025-12-31 $253,568 3,200
2025-12-31 $59,261,375 747,872
2025-09-30 $963,600 13,200
2025-09-30 $43,320,828 593,436
2025-09-30 $233,600 3,200
2025-06-30 $46,632,194 614,876
2025-03-31 $43,983,739 578,429
2024-12-31 $32,462,211 491,405
2024-09-30 $29,316,142 420,484
2024-06-30 $20,882,730 394,908